Formula Optimization of 100 mg Chewable Ascorbic Acid Tablets
Main Article Content
Abstract
Background: Ascorbic acid is a water soluble nigh dose drug that usually degrades in the presence of moisture with the formation of not so biologically active substances.. Pharmaceutical excipients have long been used to impart functionalities that improve stability and enhance patient compliance while increasing cost. Optimization therefore aims at achieving a compromise between a given set of constraints that yields the best formulation.
Objectives: The aim of this work is to produce optimised formulation of 100 mg chewable ascorbic acid tablet.
Methods: The lubricant was stearic acid at 0.25 %, 0.5% or 0.75 %. The direct compression excipient (DCE) used was Avicel® PH 102 with sorbitol as sweetener in the ratios of sorbitol to Avicel of 1:0, 0:1, 1:1 1:2, 1:3, 1: 4 respectively. The tablet weight was calculated such that the concentration of drug is 30-50% of the direct compression excipient (DCE). A step-wise optimization approach was employed. The best batch was selected as having the highest DCE dilution, hardness ≥4 kgf, minimal tablet defects, and acceptable weight variation, content and content variation.
Results: The optimal formula was obtained with the batch that has the following formula, 0.75 % stearic acid at a maximum DCE ratio of avicel: sorbitol of 4 :1 at dilution of 40 % w/w. The flow rate of the powder mix for this batch was 29.70 g/s, with Carr's compressibility index of 22%, and Hausner ratio of 1.28. The angle of o repose determined by free flow from a height of 4 cm was 23 . Drug-excipient compatibility studies using DSC revealed no significant interaction between the tablet components except possible change in crystal structure.
Conclusion: The optimal formulation had the following formula: 0.75 % stearic acid, 4 Avicel: 1 sorbitol, and at a maximum DCE dilution of 40% w/w.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Emese J and Nagymate PF (2008). The stability of Vitamin C in different Beverages. British Food Journal 110(3):296 - 309.
Davey MW, Van M, Montagn D, Inze M, Sanmartin A, Kanallis A and Smirnoff N (2000). Plant Lascorbic acid: chemistry function metabolism,
bioavailability and effects of processing. Journal of the Science of Food and Agriculture 80:825 - 60.
Chemspider. Vitamin C. Retrieved on January 17, 2016 from http://www.chemspider.com/ChemicalStructure.10189562.html
Munyaka AW, Makule E E, Oey I, Van Loey A, Hendrickx M (2010). Thermal stability of Lascorbic acid and ascorbic acid oxidase in broccoli
(Brassica oleracea var. italica). Journal of Food Science 75(4): 336-40.
Shanmugam S (2015). Granulation techniques and technologies: recent progresses. Bioimpacts 5(1):55-63.
Amrita B, Jagtap S, Rina M, Jain D (2012). Development of directly compressible ascorbic acid tablets using novel excipients. Journal of Advanced Scientific Research 3 (3): 15-24.
Jain NK (2006). Pharmaceutical product development. 1st ed. CBS Publishers and Distributors, New Delhi, pp. 295 -297.
Bushra R., Shoiab MH, Aslam N, Hashmat D and Ur-Rehman M (2008). Formulation development and optimization of ibuprofen tablets by direct compression method. Pakistani Journal of Pharmaceutical Sciences 21(2): 113-20.
Bolton S (1997). Pharmaceutical Statistics: Practical and Clinical Applications. 3rd Edition, Marcel Dekker Inc., New York, pp. 329, 345-346,
-597.
González GA (1993). Optimization of pharmaceutical formulations based on responsesurface experimental designs. International
Journal of Pharmaceutics 97(13): 149-59.
Chen Y, McCall TW, Baichwal A.R and Meyer MC (1999). The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms. Journal of Controlled Release 59:33 - 41.
Cornell JA (1990). Experiments with Mixtures. John Wiley and Sons, New York, USA, pp. 212-218.
Hobbs S K, Monsky W L, Yuan F, Roberts WG, Griffith L., Torchilin VP and Jain R K (1998). Regulation of transport pathways in tumour
vessels: Role of tumour type and microenvironment. Proceedings of the National Academy of Sciences of the United States of America 95 : 4607- 61.
Vummaneni V, Nagpal D, Surapaneni S (2012). Formulation and optimization of famotidine floating tablets using 23 factorial design. Journal of Pharmacy Research 5(12): 5280 4.
Fonner DE, Buck JR and Banker GS (1970). Mathematical optimization in drug product design and process analysis. Journal of Pharmaceutical Sciences 59:1587-96.
United States Pharmacopoeia, United States Pharmacopoeia Convention, Maryland, United States, 2005.
Science Outreach (2011). Chemistry 3.1. A program of the University of Canterbury. Retrieved online on January 11, 2016 from http://www.outreach.canterbury.ac.nz/chemistry/chem3_1index.shtml.
O'Neil MJ (2006). The Merck Index - An Encyclopaedia of Chemicals, Drugs and Biological. Whitehouse Station: Merck and Co., In., New
Jersey, p. 136.
Staniforth J N (1999). Powder Flow: in Pharmaceutics the Science of Dosage form Design. Aulton M. E. (ed). Churchill Livingstone,
London, pp. 131 - 190.
Bolhuis GK, de Waard H (2016) Compaction properties of directly compressible materials In Pharmaceutical powder compaction Technology. Second edition. Edited by Metin Celik: CRC press, Oxford (UK), pp. 143-179. Retrieved on October 10, 2016 from
http://www.crcnetbase.com/doi/abs/10.3109/9781420089189-9.
Saniocki I, Sakmann A, Albretcht S and Leopold CS (2013). Evaluation of suitability of various lubricants for direct compaction of sorbitol tablet formulations. Journal of Excipients and Food Chemistry 4(4): 169-82.
Michaud J. (2003). Crystalline sorbitol, a pharmaceutical excipient for direct compression. FaarmaChem- Pharmaceuticals: 61-64. Retrieved
on October 10, 2016 from
www.b5srl.com/downloadArticles.phpaut=MICHAUD,%20JACQUES%3Cbr%3E&mode=product&prod_down=1&product_code=0000000229&n=1&default_table=_product_due
USP 29-NF 2 (2008). United States Pharmacopoeia Convention, Maryland, United States, p. 3046.
Amrita JS, Rina B and Jain D (2012). Development of directly compressible ascorbic acid tablet using novel excipient. Journal of Advanced Scientific Research 3(3):15-24.
Wang J, Wen H, and Desai D (2010). Lubrication in tablet formulations. European Journal of Pharmaceutics and Biopharmaceutics. 75:1-15.